Double-Blind, Placebo-Controlled, Randomized Phase 2 Study of the Proapoptotic Agent AT-101 Plus Docetaxel, in Second-Line Non-small Cell Lung Cancer.

Details

Language :

English

ISSN :

15560864

Volume :

6

Issue :

4

Database :

Complementary Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Academic Journal

Accession number :

104711607

Full Text :

https://doi.org/10.1097/JTO.0b013e31820a0ea6